Pharmaceutical composition for treating myocardial hypertrophy including stem cells and a pharmaceutically acceptable carrier
TW201735935A
Pharmaceutical composition for treating diseases related to cranial nerve atrophy
TWI626052B
Injectant of composition used to repair articular cartilage characterized by facilitating the regeneration of articular cartilage to achieve the efficacy of preventing and curing arthritis
TW201822776A
Use of a pharmaceutical composition for preparing a medicament for therapy acute kidney injury
TWI611805B
Pharmaceutical composition for treating sciatic nerve injury including stem cells and platelet fibrin (PRF) release liquid
TWI608839B
Composition for treating tendonitis and manufacture thereof
TW201740959A
A pharmaceutical composition for increasing skeletal density and the using method thereof
TW201740960A
A pharmaceutical composition for treating diabetes and the using method thereof
US2016106783A1
Method for the anti-senescence of and/or rejuvenating stem cells
US2015238534A1
Novel hollow particles
TWI525193B
Uses of trans-cinnamaldehyde
TWI535446B
Method of preparing growth-factor-platelet-rich fibrin and releasate thereof
WO2016041192A1
Use of ligustilide
TW201612313A
Uses of ligustilide
TW201612314A
Uses of ligustilide for enhancing the efficacy of stem cells on treating autoimmune diseases, cardiovascular diseases, and/or hematological diseases
TW201532629A
Mesenchymal stem cell extract and its use
TW201437363A
Biohomogenizer
TW201347682A
Food supplement increase cd34+ stem cells and telomerase activity
TW201402141A
Pharmaceutical compositions to the improved sexual behavior of male
